Find your next paid study

Eikon TherapeuticsNCT06253130

~$150 – $4,200

Actual pay is set by the research site.

Development and Assessment of a Novel, Systematic Radiation Treatment Plan Evaluation Learning Tool for Radiation Oncology Residents

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to valid…

Radiation Oncology

Massachusetts General HospitalNCT06115811

Actual pay is set by the research site.

Phase 4

Cognitive, Urinary, and Functional Trajectories of Older Women Using Pharmacologic Treatment Strategies for Urgency Incontinence

The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) bet…

Urinary Incontinence, UrgeUrinary IncontinenceOveractive Bladder+3 more

University of California, San FranciscoNCT05362292

~$25 – $900

Actual pay is set by the research site.

SEntinel Lymph Node Endometrial Cancer Trial: A Prospective Multicenter International Single-Arm Observational Trial (SELECT)

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a …

Endometrial CancerEndometrioid AdenocarcinomaEndometrial Cancer Stage I

Memorial Sloan Kettering Cancer CenterNCT04291612

Actual pay is set by the research site.

Phase 3

GAIN-BCG: Gemcitabine Alternating With INtravesical BCG Randomized Against BCG Alone for Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with no…

Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8

Alliance for Clinical Trials in OncologyNCT07000084

~$50 – $1,500

Actual pay is set by the research site.

Phase 1

Phase I Trial of MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

The investigators hypothesize that MK2 inhibition may improve efficacy of mFOLFIRINOX chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC).

Metastatic Pancreatic Ductal AdenocarcinomaPancreatic CancerCancer of the Pancreas

Washington University School of MedicineNCT06648434

~$150 – $3,000

Actual pay is set by the research site.

Breast CarcinomaHead and Neck CancerLung Cancer

Respiratory Muscle Training During Cancer Treatment: Effects on the Autonomic Nervous System and Cardiotoxicity

This clinical trial evaluates whether home-based respiratory muscle training is useful for minimizing side effects in patients undergoing treatment for cancer.…

Roswell Park Cancer InstituteNCT05787834

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer With Macrovascular Invasion (HELIO-RT)

This phase III trial compares the effect of immunotherapy (IO) with stereotactic body radiation therapy (SBRT) to IO alone in treating patients with liver canc…

Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8

~$50 – $2,250

Actual pay is set by the research site.

NRG OncologyNCT07166406

Jumpstarting Advance Care Planning With ANAI People in Primary Care

The older Alaska Native/American Indian (ANAI) population is increasing at twice the rate of the general population with a higher burden of serious illness. Ol…

Advance Care Planning

Southcentral FoundationNCT06538493

Actual pay is set by the research site.

Phase 2

A Phase II Study of Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor With Fractionated Gemtuzumab Ozogamicin (CLAG-GO) for the Treatment of Patients With Persistent, Relapsed or Refractory Acute Myeloid Leukemia

This study involves evaluating a combination of chemotherapy drugs known as "CLAG-GO" \[cladribine, cytarabine, granulocyte-colony stimulating factor (G-CSF) a…

Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult

University of Maryland, BaltimoreNCT04050280

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1a/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations

This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic o…

Advanced Solid TumorMesothelioma, Malignant

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyNCT06251310

~$150 – $4,200

Actual pay is set by the research site.

Cannabis UseDepressionSuicidal Ideation+1 more

Characterizing Proximal Risk for Depressive Symptoms and Suicidal Ideation With Acute Cannabis Use and Withdrawal Among Adolescents Using Ecological Momentary Assessment

The goal of this study is to disentangle relationships between acute cannabis use and withdrawal on proximal depression and suicide risk and recovery in adoles…